These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21523472)

  • 1. The subcutaneous defibrillator will replace the transvenous defibrillator.
    Crozier I
    J Interv Card Electrophysiol; 2011 Oct; 32(1):73-7. PubMed ID: 21523472
    [No Abstract]   [Full Text] [Related]  

  • 2. Who should receive the subcutaneous implanted defibrillator?: The subcutaneous implantable cardioverter defibrillator (ICD) should be considered in all ICD patients who do not require pacing.
    Poole JE; Gold MR
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1236-44; discussion 1244-5. PubMed ID: 24347599
    [No Abstract]   [Full Text] [Related]  

  • 3. Subcutaneous implantable cardioverter-defibrillator (S-ICD).
    Lobodzinski SS
    Cardiol J; 2011; 18(3):326-31. PubMed ID: 21660928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of a subcutaneous implantable cardioverter-defibrillator in a patient with pectus excavatum.
    Osca J; Cano Ó; Izquierdo MT; Saurí A; Sancho-Tello MJ; Martínez-Dolz L
    Rev Esp Cardiol (Engl Ed); 2020 Jan; 73(1):92-94. PubMed ID: 31387797
    [No Abstract]   [Full Text] [Related]  

  • 6. Totally subcutaneous implantable cardioverter-defibrillator in a child with complex congenital heart disease and infection in a previous transvenous system.
    García-Riesco L; Pedrote A; Arana-Rueda E; Adsuar A; Arce-León Á; Guerrero-Márquez F
    Rev Esp Cardiol (Engl Ed); 2014 Nov; 67(11):961-2. PubMed ID: 25239180
    [No Abstract]   [Full Text] [Related]  

  • 7. The subcutaneous implantable cardioverter and defibrillator: advantages, limitations and future directions.
    Verma N; Rhyner J; Knight BP
    Expert Rev Cardiovasc Ther; 2015; 13(9):989-99. PubMed ID: 26308601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Extrapericardial Minimally Invasive Approach for Implantable Cardioverter Defibrillator.
    Madjarov JM; Katz MG; Poole B; Madzharov S; Fedor JM; Robicsek F
    Thorac Cardiovasc Surg; 2017 Sep; 65(6):475-478. PubMed ID: 28324909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A completely subcutaneous implantable cardioverter defibrillator in a patient with situs inversus totalis.
    van Opstal JM; Blaauw Y; Pison LP
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):333. PubMed ID: 21539637
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent developments in the subcutaneous ICD.
    Willcox ME; Prutkin JM; Bardy GH
    Trends Cardiovasc Med; 2016 Aug; 26(6):526-35. PubMed ID: 27079889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Who should receive the subcutaneous implanted defibrillator?: Timing is not right to replace the transvenous implantable cardioverter defibrillator.
    Rav Acha M; Milan D
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1246-51; discussion 1251. PubMed ID: 24347600
    [No Abstract]   [Full Text] [Related]  

  • 12. Abdominal submuscular implant of subcutaneous implantable cardioverter-defibrillator in a young child.
    Kwok SY; Yam N; Lun KS; Chen RH; Au TW; Yung TC
    Europace; 2018 Sep; 20(FI2):f248. PubMed ID: 29401320
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.
    Sinha SK; Mehta D; Gomes JA
    Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A right-sided subcutaneous implantable cardioverter defibrillator in a patient with congenital heart disease.
    Waller JR; Salmon AP; Roberts PR
    Europace; 2015 Jan; 17(1):77. PubMed ID: 25414482
    [No Abstract]   [Full Text] [Related]  

  • 15. Post-shock oversensing by a subcutaneous defibrillator resulting in inappropriate withholding of post-shock bradycardia pacing.
    Maass AH; Van Gelder IC
    Europace; 2014 Jul; 16(7):1032. PubMed ID: 24792457
    [No Abstract]   [Full Text] [Related]  

  • 16. Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter-Defibrillator Systems-A Simple Issue?
    Frommeyer G; Zumhagen S; Dechering DG; Larbig R; Bettin M; Löher A; Köbe J; Reinke F; Eckardt L
    J Am Heart Assoc; 2016 Mar; 5(3):e003181. PubMed ID: 27068637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of implantable cardioverter-defibrillator shocks on QT dispersion.
    Gurevitz O; Yaacoby E; Segal E; Perel A; Eldar M; Kaplinsky E; Glikson M
    Am J Cardiol; 2000 Nov; 86(10):1146-8, A9. PubMed ID: 11074218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Implantation of defibrillators with transvenous-subcutaneous electrode systems].
    Hief C; Podczeck A; Veit F; Frohner K; Kaltenbrunner W; Nürnberg M; Steinbach K
    Wien Klin Wochenschr; 1993; 105(1):12-6. PubMed ID: 8438594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complications in transvenous and transvenous-subcutaneous implantable defibrillator systems].
    Podczeck A; Hief C; Veit F; Jakl G; Kaltenbrunner W; Nürnberg M; Frohner K; Steinbach K
    Z Kardiol; 1994 May; 83(5):366-72. PubMed ID: 8053246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an entirely subcutaneous implantable cardioverter-defibrillator.
    Lupo PP; Pelissero G; Ali H; Sanghera R; Cappato R
    Prog Cardiovasc Dis; 2012; 54(6):493-7. PubMed ID: 22687590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.